Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer
Article in International Immunopharmacology (April 2024)
The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (April 2024)
Article in Exploration of Targeted Anti-tumor Therapy (December 2023)
Article in International Immunopharmacology (June 2023)